ICU Medical, Inc.

ICUI · NasdaqGS · Stock · Healthcare
$162.69
-0.33% today
Delayed price,

What ICU Medical does

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

Key facts

Sector
Healthcare
Industry
Medical Instruments & Supplies
Market cap
$4.07B
P/E (ttm)
136.7
Forward P/E
16.9
Dividend yield
0.00%
Beta
0.86
Profit margin
1.4%
Employees
13,000
Headquarters
San Clemente, CA, United States
Exchange
NasdaqGS

Performance

1 Month
+6.6%
3 Months
+3.3%
6 Months
+25.2%
1 Year
+37.3%
5 Years
-28.1%
$113.3752-week range$192.85
Biggest setback — last 12 months
-24.4%
16 Feb 2026 → 11 May 2026
Fell from $157.03 to $118.72 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+55.8%
13 Oct 2025 → 3 Aug 2026
Ran from $118.46 to $184.56 — its strongest sustained advance this year.

Price outlook — trend & volatility model

● Trend: Above long-term trend
Price sits above its 200-day average, but the shorter-term averages are not cleanly aligned above/below it.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$147.43 (-9.4%)$162.69$179.53 (+10.4%)
3 Months$137.17 (-15.7%)$162.69$192.95 (+18.6%)
6 Months$127.81 (-21.4%)$162.69$207.08 (+27.3%)
12 Months$115.66 (-28.9%)$162.69$228.85 (+40.7%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 34.1%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Recent insider activity

Sold 2,123 shares at $132.21 — Woolson Daniel, President · 2026-05-22
Source: SEC Form 4 filings. An "acquired" entry with no price is typically a stock award or option exercise rather than an open-market purchase. Search all insider trades →

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.